1,373 results on '"Smith, Stephen D. A."'
Search Results
2. Some results on Quillen's Conjecture via equivalent-poset techniques
3. High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series
4. Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis
5. Eliminating components in Quillen's Conjecture
6. A glimmer of hope for an Endangered temperate soft coral: the first observations of reproductive strategies and early life cycle of Dendronephthya australis (Octocorallia: Malacalcyonacea)
7. High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study
8. Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
9. Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma
10. Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL
11. They were not Silenced
12. Name, Date, Place
13. Witness within the Storm
14. All that is Real (and Some that is Not)
15. Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma
16. Eliminating components in Quillen's conjecture
17. Contrasting Mind-Wandering, (Dark) Flow, and Affect During Multiline and Single-Line Slot Machine Play
18. Realms of Digital Memory: Methodological Approaches to 360° Testimony on Location
19. Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma
20. Traits linked to sensory processing sensitivity mediate the relationship between externally oriented thinking and fantasizing
21. Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up
22. No evidence for tropicalization of coral assemblages in a subtropical climate change hot spot
23. Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
24. Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study
25. HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis
26. Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
27. Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell Lymphoma
28. Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis
29. Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
30. An electroencephalographic examination of the autonomous sensory meridian response (ASMR)
31. Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors
32. Muslim and Christian perspectives on the Holocaust and genocide
33. Introduction
34. The Routledge Handbook of Religion, Mass Atrocity, and Genocide
35. Personal philosophies of forgiveness after genocide1
36. Inside the lived perspective of life after spinal cord injury: a qualitative study of the desire to live and not live, including with assisted dying
37. Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
38. Functional connectivity associated with five different categories of Autonomous Sensory Meridian Response (ASMR) triggers
39. Early network properties of the COVID-19 pandemic – The Chinese scenario
40. Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell Lymphoma
41. An Event-Related Potential (ERP) Examination of the Neural Responses to Emotional and Movement-Related Images
42. Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study
43. Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Correlative Analysis
44. Editorial: Interdisciplinary approaches in veterinary sciences after COVID-19
45. Geo-temporal patterns to design cost-effective interventions for zoonotic diseases -the case of brucellosis in the country of Georgia
46. Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial
47. Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience
48. Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma
49. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023
50. 1423 Novel immunotherapy based on commensal-derived peptides to drive an effective CD8 T Cell response against selected tumor-associated antigens (TAAs)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.